Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...

Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...

A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...

The incidence and mortality rate of esophageal cancer in China fell by around 4.5 percent annually, according to the figures ...

Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...

Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...

When it comes to lung disease, getting answers quickly matters.  Patients across Simcoe Muskoka can now access advanced lung testing closer to home at Royal Victoria Regional Health Centre (RVH), ...

The Breakthrough Prize Foundation today announced the winners of the 2026 Breakthrough Prizes, honoring scientists whose discoveries are significantly driving growth of human knowledge. In the Life ...

Six poster presentations showcase Zymeworks’ next-generation ADC programs, including multiple first-in-class pan-RAS ...

You're reading the web version of STAT's popup newsletter, AACR in 30 seconds, your guide to what's happening at the American ...

Laureates to be Celebrated Tonight at Breakthrough Prize Ceremony in Los Angeles ...